Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Brain Metastases In ErbB2-Positive Breast Cancer
Study EGF107671 - a Phase II Study of Lapatinib Plus Topotecan or Lapatinib Plus Capecitabine in the Treatment of Recurrent Brain Metastases From ErbB2-Positive Breast Cancer Following Cranial Radiotherapy
Status: Enrolling
Updated:  9/24/2015
GSK Investigational Site
mi
from
Salzburg,
Brain Metastases In ErbB2-Positive Breast Cancer
Study EGF107671 - a Phase II Study of Lapatinib Plus Topotecan or Lapatinib Plus Capecitabine in the Treatment of Recurrent Brain Metastases From ErbB2-Positive Breast Cancer Following Cranial Radiotherapy
Status: Enrolling
Updated: 9/24/2015
GSK Investigational Site
mi
from
Salzburg,
Click here to add this to my saved trials
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated:  9/26/2015
Arizona Cancer Center
mi
from
Tucson, AZ
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated: 9/26/2015
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated:  9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated: 9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated:  9/26/2015
University of Michigan
mi
from
Ann Arbor, MI
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated: 9/26/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated:  9/26/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated: 9/26/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated:  9/26/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated: 9/26/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated:  9/26/2015
Helsinki University Central Hospital
mi
from
Helsinki,
Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
Status: Enrolling
Updated: 9/26/2015
Helsinki University Central Hospital
mi
from
Helsinki,
Click here to add this to my saved trials
Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
A Pilot Study to Evaluate Angiogenesis After Treatment With Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients With Inflammatory Breast Cancer or Locally Advanced Breast Cancer
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
A Pilot Study to Evaluate Angiogenesis After Treatment With Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients With Inflammatory Breast Cancer or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
Procurement of Normal Breast Tissue and Metastatic Breast Cancer Tissue for Molecular Profiling
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
Procurement of Normal Breast Tissue and Metastatic Breast Cancer Tissue for Molecular Profiling
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis
Evaluation of Angiogenesis Parameters and Tumor Markers in Inflammatory Breast Cancer Specimens
Status: Enrolling
Updated:  9/26/2015
GW University Medical Center GW Hospital Center
mi
from
Washington,
Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis
Evaluation of Angiogenesis Parameters and Tumor Markers in Inflammatory Breast Cancer Specimens
Status: Enrolling
Updated: 9/26/2015
GW University Medical Center GW Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
Pilot Trial to Identify and Characterize Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
Pilot Trial to Identify and Characterize Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Digital Mammography for the Detection and Preoperative Staging of Breast Cancer
Dual Energy Contrast Enhanced Digital Mammography for the Detection and Preoperative Staging of Breast Cancer
Status: Enrolling
Updated:  9/28/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Digital Mammography for the Detection and Preoperative Staging of Breast Cancer
Dual Energy Contrast Enhanced Digital Mammography for the Detection and Preoperative Staging of Breast Cancer
Status: Enrolling
Updated: 9/28/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer
Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer
Status: Enrolling
Updated:  9/28/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer
Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer
Status: Enrolling
Updated: 9/28/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo
NIR (Near Infrared Spectral Tomography)Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo.
Status: Enrolling
Updated:  9/28/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo
NIR (Near Infrared Spectral Tomography)Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo.
Status: Enrolling
Updated: 9/28/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Menopausal Symptoms in Women With Breast Cancer or At High Risk of Breast Cancer Treated on Another Clinical Trial
Menopausal Symptoms in Women With Breast Cancer
Status: Enrolling
Updated:  9/28/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Menopausal Symptoms in Women With Breast Cancer or At High Risk of Breast Cancer Treated on Another Clinical Trial
Menopausal Symptoms in Women With Breast Cancer
Status: Enrolling
Updated: 9/28/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated:  9/29/2015
University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
mi
from
Birmingham, AL
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated: 9/29/2015
University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated:  9/29/2015
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated: 9/29/2015
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated:  9/29/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated: 9/29/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated:  9/29/2015
Washington University School Of Medicine-Siteman Cancer Ctr WA Siteman
mi
from
St. Louis, MO
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated: 9/29/2015
Washington University School Of Medicine-Siteman Cancer Ctr WA Siteman
mi
from
St. Louis, MO
Click here to add this to my saved trials
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated:  9/29/2015
Beth Israel Medical Center BIMC
mi
from
New York, NY
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated: 9/29/2015
Beth Israel Medical Center BIMC
mi
from
New York, NY
Click here to add this to my saved trials
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated:  9/29/2015
Sarah Cannon Research Institute Sarah Cannon Cancer Center SC
mi
from
Nashville, TN
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated: 9/29/2015
Sarah Cannon Research Institute Sarah Cannon Cancer Center SC
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated:  9/29/2015
Karmanos Cancer Institute Dept.of KarmanosCancerInst (6)
mi
from
Detroit, MI
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated: 9/29/2015
Karmanos Cancer Institute Dept.of KarmanosCancerInst (6)
mi
from
Detroit, MI
Click here to add this to my saved trials
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated:  9/29/2015
Novartis Investigative Site
mi
from
Liege,
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
A Phase Ib/II, Open Label, Multi-center Study Evaluating the Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
Status: Enrolling
Updated: 9/29/2015
Novartis Investigative Site
mi
from
Liege,
Click here to add this to my saved trials
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated:  9/29/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated: 9/29/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated:  9/29/2015
New School for Social Research
mi
from
New York, NY
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated: 9/29/2015
New School for Social Research
mi
from
New York, NY
Click here to add this to my saved trials
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated:  9/29/2015
Spirit of Hope
mi
from
New York, NY
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated: 9/29/2015
Spirit of Hope
mi
from
New York, NY
Click here to add this to my saved trials
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated:  9/29/2015
Ralph Lauren Center for Cancer Care and Prevention
mi
from
New York, NY
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated: 9/29/2015
Ralph Lauren Center for Cancer Care and Prevention
mi
from
New York, NY
Click here to add this to my saved trials
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated:  9/29/2015
SHARE, Incorporated
mi
from
New York, NY
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated: 9/29/2015
SHARE, Incorporated
mi
from
New York, NY
Click here to add this to my saved trials
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated:  9/29/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
Status: Enrolling
Updated: 9/29/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
Psychosocial Adjustment During the Post-Radiation Treatment Transition
Status: Enrolling
Updated:  9/29/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
Psychosocial Adjustment During the Post-Radiation Treatment Transition
Status: Enrolling
Updated: 9/29/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Prevention of Paclitaxel Neuropathy With Cryotherapy
Prevention of Paclitaxel Neuropathy With Cryotherapy
Status: Enrolling
Updated:  9/30/2015
Medical Oncology and Hematology Associates of Northern Virginia
mi
from
Fairfax, VA
Prevention of Paclitaxel Neuropathy With Cryotherapy
Prevention of Paclitaxel Neuropathy With Cryotherapy
Status: Enrolling
Updated: 9/30/2015
Medical Oncology and Hematology Associates of Northern Virginia
mi
from
Fairfax, VA
Click here to add this to my saved trials
Prevention of Paclitaxel Neuropathy With Cryotherapy
Prevention of Paclitaxel Neuropathy With Cryotherapy
Status: Enrolling
Updated:  9/30/2015
Medical Oncology & Hematology Associates of Northern Virginia
mi
from
Reston, VA
Prevention of Paclitaxel Neuropathy With Cryotherapy
Prevention of Paclitaxel Neuropathy With Cryotherapy
Status: Enrolling
Updated: 9/30/2015
Medical Oncology & Hematology Associates of Northern Virginia
mi
from
Reston, VA
Click here to add this to my saved trials
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
Status: Enrolling
Updated:  9/30/2015
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
Status: Enrolling
Updated: 9/30/2015
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
Uh-Luicc
mi
from
Mentor, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
Uh-Luicc
mi
from
Mentor, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
UH-Green Road
mi
from
South Euclid, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
UH-Green Road
mi
from
South Euclid, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
UH-Chagrin Highlands
mi
from
Orange Village, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
UH-Chagrin Highlands
mi
from
Orange Village, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
UH-Westlake
mi
from
Westlake, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
UH-Westlake
mi
from
Westlake, OH
Click here to add this to my saved trials
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Aurora, CO
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Boston, MA
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
New York, NY
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Stanford, CA
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Detroit, MI
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
A Phase Ib-IIa, Open-label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Trastuzumab Emtansine, Paclitaxel and Pertuzumab Administered Intravenously to Patients With Her2-positive, Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer
Pilot Phase I/II Investigational Study to Assess the Efficacy and Safety of Recombinant Hyaluronidase (rHUPH20) in the Treatment of Secondary Lymphedema Resulting From Local Management of Malignancy
Status: Enrolling
Updated:  10/1/2015
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer
Pilot Phase I/II Investigational Study to Assess the Efficacy and Safety of Recombinant Hyaluronidase (rHUPH20) in the Treatment of Secondary Lymphedema Resulting From Local Management of Malignancy
Status: Enrolling
Updated: 10/1/2015
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Trastuzumab [Herceptin†]
Status: Enrolling
Updated:  10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Trastuzumab [Herceptin†]
Status: Enrolling
Updated: 10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
Tower Cancer Research Foundation
mi
from
Beverly Hills, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
Tower Cancer Research Foundation
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
Hematology Oncology Consultants-Hemet
mi
from
Hemet, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
Hematology Oncology Consultants-Hemet
mi
from
Hemet, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials